The Eμ-myc transgenic mouse expresses elevated levels of c-Myc in the B cell lineage and develops B cell lymphomas with associated mutations in p53 or other genes linked to apoptosis. This evidence concerns the gene TP53 and B-cell non-Hodgkin lymphoma.